Erratum: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12- week results from a randomized, doubleblind, placebo-controlled phase 3b study (PLoS ONE (2021) 16:2 (e0245827) DOI: 10.1371/journal.pone.0245827)

Atul T. Patel, Mark F. Lew, Khashayar Dashtipour, Stuart Isaacson, Robert A. Hauser, William Ondo, Pascal Maisonobe, Stefan Wietek, Bruce Rubin, Allison Brashear

Research output: Contribution to journalComment/debatepeer-review

Abstract

In Fig 2, the delta and p-value are missing for the last available post-baseline assessment. The missing information reflects a statistically significant difference in the mean TWSTRS total score of aboBoNT-A vs placebo at the last available data point. Please see the correct Fig 2 here. (Figure Presented).

Original languageEnglish (US)
Article numbere0250475
JournalPloS one
Volume16
Issue number4 April
DOIs
StatePublished - Apr 2021

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Erratum: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12- week results from a randomized, doubleblind, placebo-controlled phase 3b study (PLoS ONE (2021) 16:2 (e0245827) DOI: 10.1371/journal.pone.0245827)'. Together they form a unique fingerprint.

Cite this